Inactive Instrument

CM LIFE Stock price

Equities

CMLT

US1258411065

Dynamic Chart
Drug Firm EQRx to Make Nasdaq Debut Monday After Merger Deal With Blank Check Company MT
CM Life Sciences III Inc.(NasdaqCM:CMLT) dropped from NASDAQ Composite Index CI
EQRx, Inc. completed the acquisition of CM Life Sciences III Inc. from CMLS Holdings III LLC and others in a reverse merger transaction. CI
EQRx, Inc. and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination CI
CM Life Sciences III : EQRx to Collaborate With England's National Health Service Over Cheaper Cancer Medicines MT
Certain Class B Common Stock of CM Life Sciences III Inc. are subject to a Lock-Up Agreement Ending on 4-OCT-2021. CI
CM Life Sciences III : Agree to Business Combination; Shares Rise Early MT
EQRx, Inc. executed a non-binding Letter of intent to acquire CM Life Sciences III Inc. from CMLS Holdings III LLC and others for $4.2 billion in a reverse merger transaction. CI
CM Life Sciences III Inc. Appoints Amy Abernethy as Director CI
CM Life Sciences III Inc.(NasdaqCM:CMLT) added to NASDAQ Composite Index CI
CM Life Sciences III Inc. has completed an IPO in the amount of $480 million. CI
CM Life Sciences III Inc. announced that it has received $163.04 million in funding from CMLS Holdings III LLC, Casdin Capital, LLC, Corvex Management LP and other investors CI
CM Life Sciences III Inc. has filed an IPO in the amount of $400 million. CI
CM Life Sciences III Inc. announced that it expects to receive $160.000001 million in funding from CMLS Holdings III LLC, Casdin Capital, LLC, Corvex Management LP and other investors CI
More news
CM Life Sciences III Inc is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target. The Company intends to execute business combination in the life sciences sector.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock CM LIFE - Nasdaq